• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同pT分期胃癌的转移淋巴结比率与预后

Metastatic lymph node ratio and prognosis of gastric cancer at different pT stages.

作者信息

Li Xiaobao, Liu Yongfeng, Cao Bo, Liu Bin, Bai Tiecheng, Li Xiaoyong, Mei Leyuan, Che Xiangming

出版信息

Hepatogastroenterology. 2015 Mar-Apr;62(138):507-11.

PMID:25916091
Abstract

BACKGROUND/AIMS: This study aimed to investigate the role of metastatic lymph node ratio (MLR) in the evaluation of prognosis of patients with gastric cancer at different T stages.

METHODOLOGY

Clinical information was reviewed retrospectively in a total 535 patients who underwent surgery for gastric cancer. The prognostic value of MLR was compared with that of pN determined according to the UICC/AJCC guidelines (7th Edition), and the characteristics and advantages of MLR were analyzed. Moreover, the role of MLR in the evaluation of prognosis of patients with gastric cancer at different pT stages was investigated.

RESULTS

Univariate Kaplan-Meier method was used for the analysis of survival, and the results showed that MLR was closely associated with the prognosis of these patients. Multivariate analysis with Cox proportional hazards regression model showed that MLR was a major independent risk factor in the prognosis of gastric cancer patients. The area under the ROC curve of MLR in predicting the death of gastric cancer patients within 5 years after surgery was not associated with pN stage. MLR was effective in predicting the prognosis of patients with stage pT2 or pT3 gastric cancer (P < 0.05).

CONCLUSIONS

MLR is an independent risk factor in the prognosis of gastric cancer. MLR has a prognostic ability comparable to that of pN stage in gastric cancer. Thus, it is more reliable than pN in the evaluation of prognosis of gastric cancer patients, especially those with stage pT2-pT3 gastric cancer.

摘要

背景/目的:本研究旨在探讨转移淋巴结比率(MLR)在评估不同T分期胃癌患者预后中的作用。

方法

回顾性分析535例行胃癌手术患者的临床资料。将MLR的预后价值与根据UICC/AJCC指南(第7版)确定的pN的预后价值进行比较,并分析MLR的特点和优势。此外,研究MLR在评估不同pT分期胃癌患者预后中的作用。

结果

采用单因素Kaplan-Meier法分析生存率,结果显示MLR与这些患者的预后密切相关。Cox比例风险回归模型多因素分析显示,MLR是胃癌患者预后的主要独立危险因素。MLR预测胃癌患者术后5年内死亡的ROC曲线下面积与pN分期无关。MLR对pT2或pT3期胃癌患者的预后有预测作用(P<0.05)。

结论

MLR是胃癌预后的独立危险因素。MLR在胃癌中的预后评估能力与pN分期相当。因此,在评估胃癌患者,尤其是pT2-pT3期胃癌患者的预后时,MLR比pN更可靠。

相似文献

1
Metastatic lymph node ratio and prognosis of gastric cancer at different pT stages.不同pT分期胃癌的转移淋巴结比率与预后
Hepatogastroenterology. 2015 Mar-Apr;62(138):507-11.
2
[Prognostic value of metastatic lymph node ratio in adenocarcinoma of the gastroesophageal junction].[胃食管交界腺癌中转移淋巴结比率的预后价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Sep;16(9):822-6.
3
Ratio of metastatic to examined lymph nodes is a predictor of mortality in locally advanced gastric cancer treated chemo-radiotherapy.转移性淋巴结与检查的淋巴结的比例是接受放化疗的局部晚期胃癌患者死亡率的一个预测指标。
Hepatogastroenterology. 2014 Oct;61(135):2141-8.
4
Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.无论检查的淋巴结数量多少,淋巴结比率都是可切除(R0)胃癌患者的独立预后因素。
Am J Clin Oncol. 2013 Aug;36(4):325-30. doi: 10.1097/COC.0b013e318246b4e9.
5
[The value of metastatic lymph nodes ratio in predicting the prognosis of patients with T3 gastric carcinoma].[转移淋巴结比率在预测T3期胃癌患者预后中的价值]
Zhonghua Yi Xue Za Zhi. 2005 Apr 6;85(13):922-5.
6
[Prognostic value of metastatic lymph node ratio for patients with gastric cancer].[胃癌患者转移性淋巴结比率的预后价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Jul;14(7):516-9.
7
[Prognostic value of metastatic lymph node ratio for gastric cancer patients with less than 15 lymph nodes dissection].[转移淋巴结比率对淋巴结清扫数少于15枚的胃癌患者的预后价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Feb;16(2):151-4.
8
Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.确定接受胃癌 D2 清扫术患者的转移性淋巴结比率。
Med Oncol. 2010 Sep;27(3):975-84. doi: 10.1007/s12032-009-9319-4. Epub 2009 Nov 3.
9
[Prognostic value of metastatic lymph node ratio in gastric cancer patients undergoing radical gastrectomy].[胃癌根治性切除患者转移性淋巴结比率的预后价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jan;16(1):56-9.
10
Prognostic impact of positive lymph node ratio in gastric carcinoma.胃癌中阳性淋巴结比率的预后影响
J Surg Oncol. 2007 Aug 1;96(2):95-101. doi: 10.1002/jso.20797.

引用本文的文献

1
Preoperative Plasma Fibrinogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer.术前血浆纤维蛋白原和血清白蛋白评分是可切除 II-III 期胃癌的独立预后因素。
Dis Markers. 2019 Oct 29;2019:9060845. doi: 10.1155/2019/9060845. eCollection 2019.
2
Risk factors for lymph node metastasis of early gastric cancers in patients younger than 40.40岁以下早期胃癌患者淋巴结转移的危险因素
Medicine (Baltimore). 2017 Sep;96(37):e7874. doi: 10.1097/MD.0000000000007874.
3
Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes.
基于淋巴结比率的列线图可预测可切除胃癌的生存率,无论检查的淋巴结数量如何。
Oncotarget. 2017 Jul 11;8(28):45585-45596. doi: 10.18632/oncotarget.17276.
4
Surgical Outcomes Associated with Operable Gastric Cancer in a Tertiary Care Indian Hospital.印度一家三级医疗医院中可手术胃癌的手术结果
J Gastric Cancer. 2017 Mar;17(1):63-73. doi: 10.5230/jgc.2017.17.e7. Epub 2017 Mar 20.
5
Validation of the 7th AJCC/UICC staging system for gastric cancer and a proposal for a new TNM system based on a prognostic score: a retrospective multicenter study.第七版美国癌症联合委员会(AJCC)/国际抗癌联盟(UICC)胃癌分期系统的验证以及基于预后评分的新TNM系统的提议:一项回顾性多中心研究
Ann Surg Treat Res. 2016 Dec;91(6):295-302. doi: 10.4174/astr.2016.91.6.295. Epub 2016 Nov 25.
6
Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center.基于淋巴结比率的分期系统在2575例胃癌患者预后预测中的优越性:大型单中心验证分析
Oncotarget. 2016 Aug 9;7(32):51069-51081. doi: 10.18632/oncotarget.9714.
7
Preoperative SCC Antigen, CRP Serum Levels, and Lymph Node Density in Oral Squamous Cell Carcinoma.口腔鳞状细胞癌的术前鳞状细胞癌抗原、血清C反应蛋白水平及淋巴结密度
Medicine (Baltimore). 2016 Apr;95(14):e3149. doi: 10.1097/MD.0000000000003149.